(Q40394347)

20 September 2017

1 reference

title

Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension (English)

1 reference

20 September 2017

1 reference

1 reference

L R Wiseman

1

1 reference

20 September 2017

D McTavish

series ordinal

2

1 reference

20 September 2017

publication date

1 July 1994

1 reference

20 September 2017

1 reference

20 September 2017

volume

48

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

71-90

1 reference

Cardiac effects of trandolapril in hypertension

20 September 2017

cites work

1 reference

12 December 2020

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

1 reference

12 December 2020

[Action of trandolapril on the blood glucose balance and microalbuminuria in hypertensive diabetics]

1 reference

12 December 2020

Efficacy and tolerance of trandolapril (0.5-2 mg) administered for 4 weeks in patients with mild-to-moderate hypertension. Investigator Study Group

1 reference

12 December 2020

Converting enzyme inhibition: dissociation between antihypertensive and arterial effects

1 reference

12 December 2020

Long-term therapy with trandolapril, a new nonsulfhydryl ACE inhibitor, in hypertension: a multicenter international trial. Investigator Study Group.

1 reference

12 December 2020

Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to young and elderly patients with mild-to-moderate hypertension

1 reference

12 December 2020

Influence of the nonsulfhydryl angiotensin-converting enzyme inhibitor trandolapril on lipid and carbohydrate metabolism related to exercise capacity in healthy subjects

1 reference

12 December 2020

Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of trandolapril after repeated administration of 2 mg to patients with chronic renal failure and healthy control subjects

1 reference

12 December 2020

Pharmacological activity and safety of trandolapril (RU 44570) in healthy volunteers

1 reference

12 December 2020

Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group

1 reference

12 December 2020

Compared properties of trandolapril, enalapril, and their diacid metabolites

1 reference

12 December 2020

Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group

1 reference

12 December 2020

Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats

1 reference

12 December 2020

Circulating versus local renin-angiotensin system in cardiovascular homeostasis.

1 reference

12 December 2020

Pharmacokinetics of fosinopril in patients with various degrees of renal function

1 reference

12 December 2020

Angiotensin-converting enzyme in rat brain and extraneural tissues visualized by quantitative autoradiography using 3H-trandolaprilate

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570)

1 reference

12 December 2020

Effects of blood pressure reduction with trandolapril and enalapril on left ventricular hypertrophy and exercise tolerance

1 reference

12 December 2020

Clinical experiences with trandolapril

1 reference

12 December 2020

Effects of Antihypertensive Treatment on Insulin Sensitivity With Special Reference to ACE Inhibitors

1 reference

12 December 2020

Metabolic considerations in the choice of therapy for the patient with hypertension

1 reference

12 December 2020

Effect of renal function on the pharmacokinetics and pharmacodynamics of trandolapril

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Trandolapril: pharmacokinetics of single oral doses in healthy male volunteers

1 reference

12 December 2020

Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor

1 reference

12 December 2020

Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures.

1 reference

12 December 2020

Treatment selection considerations for the hypertensive diabetic patient

1 reference

12 December 2020

Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin

1 reference

12 December 2020

Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.

1 reference

12 December 2020

Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme

1 reference

12 December 2020

Effects of trandolapril on 24-h ambulatory blood pressure in patients with mild-to-moderate essential hypertension

1 reference

12 December 2020

Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group

1 reference

12 December 2020

10.2165/00003495-199448010-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1013914322

0 references

1 reference